Patients with Charcot-Marie-Tooth Type 2D (CMT2D), caused by dominant mutations in Glycl tRNA synthetase (GARS), present with progressive weakness, consistently in the hands, but often in the feet...
J. Neurosci. - issue: 11 - volume: 36 - pages: 3254-3267.